Shandong Buchang Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Shandong Buchang Pharmaceuticals has a total shareholder equity of CN¥11.3B and total debt of CN¥3.7B, which brings its debt-to-equity ratio to 32.5%. Its total assets and total liabilities are CN¥21.3B and CN¥10.0B respectively. Shandong Buchang Pharmaceuticals's EBIT is CN¥919.2M making its interest coverage ratio -63.1. It has cash and short-term investments of CN¥1.4B.
Key information
32.5%
Debt to equity ratio
CN¥3.68b
Debt
| Interest coverage ratio | -63.1x |
| Cash | CN¥1.37b |
| Equity | CN¥11.32b |
| Total liabilities | CN¥9.99b |
| Total assets | CN¥21.31b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 603858's short term assets (CN¥8.7B) exceed its short term liabilities (CN¥6.9B).
Long Term Liabilities: 603858's short term assets (CN¥8.7B) exceed its long term liabilities (CN¥3.1B).
Debt to Equity History and Analysis
Debt Level: 603858's net debt to equity ratio (20.4%) is considered satisfactory.
Reducing Debt: 603858's debt to equity ratio has increased from 15.9% to 32.5% over the past 5 years.
Debt Coverage: 603858's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 603858 earns more interest than it pays, so coverage of interest payments is not a concern.